Le Lézard
Classified in: Health
Subjects: HEALTH, GOVERNMENT CONTRACTS

New report exposes harmful impact of Ford government's privatization scheme on local public hospitals: Health Coalition


TORONTO, Feb. 18, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department wait times, burgeoning deficits, and an unrelenting staffing crisis, it is running high-rotation advertisements paid for by the public to convince Ontarians that they are doing all they can to improve our health care. A new report to be released by the Ontario Health Coalition takes aim at those claims and exposes the impact of the Ford government's drive to privatize public hospital services on local public hospitals across the province. The report, based on a year-long study looking at local hospitals across Ontario, reveals the concrete costs ? both financial costs to patients and the province and services losses to local communities-- of the transfer of resources away from our public hospitals to for-profit clinics and hospitals. The report includes information on hospitals in every region of the province.

When:  Wednesday, February 21
 12:15 p.m. Queen's Park Media Studio, Main Legislative Building, Toronto.
 1 p.m. Brampton - Outside Brampton Civic Hospital, corner of Bramalea Rd & Bovaird Dr.
 12 p.m. Cornwall - Automotive Room, Benson Centre, 800 Seventh St. W.
 11 a.m. London - Tonda Room, Central Public Library, 251 Dundas St.
 11 a.m. Niagara - Room 108-09, Welland Civic Square, 60 East Main St. Welland
 10 a.m. Waterloo - Board Room, Waterloo Public Library, 35 Albert St.


More communities will be joining in. Updated information will be sent out on Tuesday.

For more information:

Ontario-wide ? Natalie Mehra (cell) 416-230-6402 [email protected] 
Brampton ? Janine Herrmann-McLeod 647-237-6276 [email protected] 
Cornwall ? Elaine MacDonald 613-330-3117 [email protected]
London ? Peter Bergmanis 519-860-4403 [email protected]
Niagara ? Sue Hotte 905-9322-1646 [email protected]
Waterloo ? Jim Stewart 519-588-5841 [email protected]

 



These press releases may also interest you

at 09:05
Smart Meter Introduces World's First Cellular-Enabled Glucose Meter with Notifications and Multi-Language Capabilities
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...

at 09:00
Ministers Anandasangaree, Hajdu, Vandal, and Ien issue statement on Red Dress Day 2024
Today, the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations; the Honourable Patty Hajdu, Minister of Indigenous Services and Minister responsible for FedNor; the Honourable Dan Vandal, Minister of Northern Affairs; and the...

at 08:05
Pushing the Boundaries of Neuroscience with GE HealthCare's SIGNA MAGNUS
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
2024 National Hospice Palliative Care Week 2024 - Palliative Care Means Living Well: Let's Talk About it!
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
Brazilian Doctor Ushering in New Era of Medical Technology for Treating Cancer and Seeks to Bring Proton Therapy to Brazil
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

More news about Health...


News published on and distributed by: